How to buy Generation Bio (GBIO) stock

Generation Bio Co is a biotechnology business based in the US. Generation Bio shares (GBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Generation Bio employs 100 staff and has a market cap (total outstanding shares value) of 0.00.

Generation Bio stock price (NASDAQ: GBIO)

Use our graph to track the performance of GBIO stocks over time.

Generation Bio shares at a glance

• Key figures

Information last updated 2021-07-15.

Latest market close	$34.26
52-week range	$18.80 - $55.72
50-day moving average	$27.07
200-day moving average	$30.56
Wall St. target price	$42.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.13

Buy Generation Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Generation Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Generation Bio Co by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Generation Bio price performance over time

Historical closes compared with the close of $34.26 from 2021-05-28

1 week (2021-07-12)	N/A
1 month (2021-06-23)	33.46%
3 months (2021-04-19)	N/A
6 months (2021-01-19)	N/A

1 year (2020-07-19)	N/A
2 years (2019-07-19)	N/A
3 years (2018-07-19)	N/A
5 years (2016-07-19)	N/A

Generation Bio financials

Gross profit TTM	$0
Return on assets TTM	-17.15%
Return on equity TTM	-31.09%
Profit margin	0%
Book value	N/A
Market capitalisation	$1.1 billion

TTM: trailing 12 months

Shorting Generation Bio shares

There are currently 5.8 million Generation Bio shares held short by investors – that's known as Generation Bio's "short interest". This figure is 5.2% up from 5.5 million last month.

There are a few different ways that this level of interest in shorting Generation Bio shares can be evaluated.

Generation Bio's "short interest ratio" (SIR)

Generation Bio's "short interest ratio" (SIR) is the quantity of Generation Bio shares currently shorted divided by the average quantity of Generation Bio shares traded daily (recently around 444296.25382263). Generation Bio's SIR currently stands at 13.08. In other words for every 100,000 Generation Bio shares traded daily on the market, roughly 13080 shares are currently held short.

However Generation Bio's short interest can also be evaluated against the total number of Generation Bio shares, or, against the total number of tradable Generation Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Generation Bio's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Generation Bio shares in existence, roughly 100 shares are currently held short) or 0.1547% of the tradable shares (for every 100,000 tradable Generation Bio shares, roughly 155 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Generation Bio.

Find out more about how you can short Generation Bio stock.

Generation Bio share dividends

We're not expecting Generation Bio to pay a dividend over the next 12 months.

Generation Bio overview

Generation Bio Co. , a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.

Frequently asked questions

What percentage of Generation Bio is owned by insiders or institutions?
Currently 8.689% of Generation Bio shares are held by insiders and 95.474% by institutions. How many people work for Generation Bio?
Latest data suggests 100 work at Generation Bio. When does the fiscal year end for Generation Bio?
Generation Bio's fiscal year ends in December. Where is Generation Bio based?
Generation Bio's address is: 301 Binney Street, Cambridge, MA, United States, 02142 What is Generation Bio's ISIN number?
Generation Bio's international securities identification number is: US37148K1007